Dr. Williams completed a PhD in Biomedical Sciences (Immunology and Microbiology) from the University of Florida and did his postdoctoral work in the laboratory of Dr. Barton Haynes at the Duke Human Vaccine Institute (DHVI).
The key goals of HIV vaccine development are to define the host-virus events during natural HIV infection that lead to the induction of broadly neutralizing antibodies, and to recreate those events with a vaccine. As a junior faculty member in the DHVI, Dr. Williams is further characterizing SHIV non-human primate models for HIV infection, and evaluates B cell responses to HIV-1 vaccination in humans and non-human primates.
Education and Training
- Ph.D., University of Florida, 2011
In the News
- Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
- Interdisciplinary Research Training Program in AIDS
- Neonatal Immunity to novel TF SHIVs
- SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design
- Immunogen Design of HIV Sequential Envelopes Derived from SHIV-infected Macaques
- Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunity